Literature DB >> 27265891

Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ).

Simon D Brandt1, Pierce V Kavanagh2, Folker Westphal3, Simon P Elliott4, Jason Wallach5, Tristan Colestock6, Timothy E Burrow7, Stephen J Chapman8, Alexander Stratford9, David E Nichols10, Adam L Halberstadt11.   

Abstract

Lysergic acid N,N-diethylamide (LSD) is perhaps one of the most intriguing psychoactive substances known and numerous analogs have been explored to varying extents in previous decades. In 2013, N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ) appeared on the 'research chemicals'/new psychoactive substances (NPS) market in both powdered and blotter form. This study reports the analytical characterization of powdered AL-LAD and LSZ tartrate samples and their semi-quantitative determination on blotter paper. Included in this study was the use of nuclear magnetic resonance (NMR) spectroscopy, gas chromatography-mass spectrometry (GC-MS), low and high mass accuracy electrospray MS(/MS), high performance liquid chromatography diode array detection and GC solid-state infrared analysis. One feature shared by serotonergic psychedelics, such as LSD, is the ability to mediate behavioural responses via activation of 5-HT2A receptors. Both AL-LAD and LSZ displayed LSD-like responses in male C57BL/6 J mice when employing the head-twitch response (HTR) assay. AL-LAD and LSZ produced nearly identical inverted-U-shaped dose-dependent effects, with the maximal responses occurring at 200 µg/kg. Analysis of the dose responses by nonlinear regression confirmed that LSZ (ED50  = 114.2 nmol/kg) was equipotent to LSD (ED50  = 132.8 nmol/kg) in mice, whereas AL-LAD was slightly less potent (ED50  = 174.9 nmol/kg). The extent to which a comparison in potency can be translated directly to humans requires further investigation. Chemical and pharmacological data obtained from NPS may assist research communities that are interested in various aspects related to substance use and forensic identification.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  5-HT2A receptors; LSD; lysergamides; new psychoactive substances; psychedelics

Mesh:

Substances:

Year:  2016        PMID: 27265891      PMCID: PMC5411264          DOI: 10.1002/dta.1985

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  21 in total

Review 1.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

2.  Actions of D-lysergic acid diethylamide (LSD) and its derivatives on 5-hydroxytryptamine receptors in the isolated uterine smooth muscle of the rat.

Authors:  H Hashimoto; M Hayashi; Y Nakahara; T Niwaguchi; H Ishii
Journal:  Eur J Pharmacol       Date:  1977-10-15       Impact factor: 4.432

3.  Infrared identification of lysergide (LSD).

Authors:  R J Mesley; W H Evans
Journal:  J Pharm Pharmacol       Date:  1969-11       Impact factor: 3.765

4.  Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.

Authors:  H Hashimoto; M Hayashi; Y Nakahara; T Niwaguchi; H Ishii
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-08

5.  Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes.

Authors:  A P Monte; D Marona-Lewicka; A Kanthasamy; E Sanders-Bush; D E Nichols
Journal:  J Med Chem       Date:  1995-03-17       Impact factor: 7.446

6.  Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry.

Authors:  J Cai; J Henion
Journal:  J Anal Toxicol       Date:  1996 Jan-Feb       Impact factor: 3.367

Review 7.  Stereoselective pharmacological effects of lysergic acid amides possessing chirality in the amide substituent.

Authors:  D E Nichols; A Monte; X Huang; D Marona-Lewicka
Journal:  Behav Brain Res       Date:  1996       Impact factor: 3.332

8.  Studies of the relationship between molecular structure and hallucinogenic activity.

Authors:  D E Nichols
Journal:  Pharmacol Biochem Behav       Date:  1986-02       Impact factor: 3.533

9.  Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).

Authors:  David E Nichols; Stewart Frescas; Danuta Marona-Lewicka; Deborah M Kurrasch-Orbaugh
Journal:  J Med Chem       Date:  2002-09-12       Impact factor: 7.446

10.  LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.

Authors:  V J Watts; C P Lawler; D R Fox; K A Neve; D E Nichols; R B Mailman
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

View more
  19 in total

1.  Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Simon P Elliott; Jason Wallach; Alexander Stratford; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2017-05-10       Impact factor: 3.345

2.  Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017.

Authors:  Joseph J Palamar; Austin Le
Journal:  Hum Psychopharmacol       Date:  2019-03-06       Impact factor: 1.672

Review 3.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

4.  Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

Authors:  Clinton E Canal
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).

Authors:  Simon D Brandt; Pierce V Kavanagh; Brendan Twamley; Folker Westphal; Simon P Elliott; Jason Wallach; Alexander Stratford; Landon M Klein; John D McCorvy; David E Nichols; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2017-07-27       Impact factor: 3.345

6.  Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).

Authors:  Simon D Brandt; Pierce V Kavanagh; Folker Westphal; Alexander Stratford; Simon P Elliott; Geraldine Dowling; Jason Wallach; Adam L Halberstadt
Journal:  Drug Test Anal       Date:  2019-06-18       Impact factor: 3.345

Review 7.  Effect of Hallucinogens on Unconditioned Behavior.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2018

8.  Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.

Authors:  Adam L Halberstadt; Muhammad Chatha; Stephen J Chapman; Simon D Brandt
Journal:  J Psychopharmacol       Date:  2019-02-21       Impact factor: 4.153

9.  Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).

Authors:  Adam L Halberstadt; Landon M Klein; Muhammad Chatha; Laura B Valenzuela; Alexander Stratford; Jason Wallach; David E Nichols; Simon D Brandt
Journal:  Psychopharmacology (Berl)       Date:  2018-10-08       Impact factor: 4.530

10.  Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).

Authors:  Adam L Halberstadt; Muhammad Chatha; Adam K Klein; John D McCorvy; Markus R Meyer; Lea Wagmann; Alexander Stratford; Simon D Brandt
Journal:  Neuropharmacology       Date:  2019-11-19       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.